Mediwatch PLC Cancellation of Mediwatch Shares (5025Y)

TIDMMDW

RNS Number : 5025Y

Mediwatch PLC

24 January 2014

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO ANY RESTRICTED JURISDICTIONS OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

Mediwatch plc

Amendment to time of cancellation of admission of Mediwatch Shares to trading on AIM

24 January 2014

Further to the announcement made on 22 January 2014, the Mediwatch Directors announce that due to the change in court availability and the Reduction Court Hearing consequently taking place on 27 January 2014, it is expected that the cancellation of the admission of Mediwatch Shares to trading on AIM will occur at 7.00 a.m. (London time) on 28 January 2014.

A further announcement will be made following the Reduction Court Hearing on 27 January 2014.

Enquiries:

 
 Mediwatch                                         [phone] 
  Mark Hughes, Chief Financial Officer                          888 
 SP Angel Corporate Finance LLP 
  (Financial adviser, nominated adviser and 
  broker to Mediwatch) 
  David Facey 
  Katy Birkin 
  Liz Yong                                     [phone] 
 

Important Notice

This announcement is for information purposes only and does not constitute an offer to sell or an invitation to sell, purchase, subscribe for or issue any securities, or the solicitation of an offer to subscribe for any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Acquisition or otherwise, nor shall there be any purchase, sale or exchange of securities or such solicitation in any jurisdiction in which such offer, solicitation, sale or exchange would be unlawful under the laws of such jurisdiction. Any response to the Acquisition or vote in respect of the Scheme should be made only on the basis of the information contained in the Scheme Document.

The release, publication or distribution of this announcement in jurisdictions other than the United Kingdom may be restricted by law and therefore any persons who are subject to the laws of any jurisdiction other than the United Kingdom should inform themselves about, and observe, any applicable requirements. This announcement has been prepared for the purpose of complying with English law and the City Code and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws of jurisdictions outside the United Kingdom.

Copies of this announcement and any formal documentation relating to the Acquisition are not being, and must not be, directly or indirectly, mailed or otherwise forwarded, distributed or sent in or into or from any Restricted Jurisdiction and persons receiving such documents (including custodians, nominees and trustees) must not mail or otherwise forward, distribute or send them in or into or from any Restricted Jurisdiction.

SP Angel Corporate Finance LLP, which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting exclusively as financial adviser to Mediwatch and no one else in connection with the matters described in this announcement, and will not be responsible for anyone other than Mediwatch for providing the protections afforded to clients of SP Angel Corporate Finance LLP nor for providing advice in relation to the matters referred to in this announcement. Neither SP Angel Corporate Finance LLP nor any of its affiliates, partners or employees owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of SP Angel Corporate Finance LLP in connection with this announcement, any statement contained herein or otherwise.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCEZLFLZFFXBBX